Search results
Can multiple myeloma be cured? Treatments and outlook
Medical News Today· 7 days agoConsolidation: This is only if a person is to receive a stem cell transplant. Maintenance: This...
Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
Morningstar· 6 days agoKite, a Gilead Company (NASDAQ: GILD), and Arcellx, Inc. (NASDAQ: ACLX) today announced several key operational updates on their partnered anitocabtagene autoleucel (anito-cel) multiple ...
Kite and Arcellx prepare to launch Phase III multiple myeloma trial
Clinical Trials Arena via Yahoo Finance· 5 days agoKite, a Gilead Company, and Arcellx have announced plans to commence a Phase III clinical trial of...
What Can I Do To Prevent Spondylolisthesis From Getting Worse? A Review By Doctors
MSN News· 16 hours agoExpert opinion from Gustavo Campos Doctor of Medicine · 9 years of experience · Brazil It's...
Earnings call: Legend Biotech reports robust growth with CARVYKTI By Investing.com
Investing.com· 2 days agoLegend Biotech (NASDAQ: LEGN) has announced significant growth in its first-quarter financial...
Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024
WRBL Columbus· 17 hours ago...proprietary allogeneic CAR-T platform to develop cell therapies targeting solid tumors Generated $95 million in milestone and upfront payments to-date in 2024, including $50 million from Astellas collaboration and $45 million from continued execution in the Company's CAR-T partnership with Roche...
Dangers firefighters face include higher cancer risks
United Press International via Yahoo News· 5 days agoFor 14 years, David Perez fought fires in South Florida, thinking he was in peak physical shape....
Kite and Arcellx to start Phase 3 trial for myeloma therapy By Investing.com
Investing.com· 6 days ago(NASDAQ: ACLX) have announced their upcoming Phase 3 clinical trial for anitocabtagene autoleucel...
Cool Teachers: Mrs. Jodi Caruso and Mrs. Suzi Cunningham
WCBD-TV Charleston· 26 minutes agoWe just celebrated Mother’s Day, and a mother-daughter teaching duo at St. Andrew’s School of Math...
Legend Biotech 1Q Loss Narrows with Higher Carvykti Sales
Morningstar· 2 days agoBy Dean Seal Legend Biotech narrowed its loss in the first quarter as revenue climbed on higher sales of its multiple myeloma treatment Carvykti. The cell ...